Intriguingly, melanoma-associated RAC1-activating mutations seem to be mutually exclusive with PTEN loss, suggesting a scenario whereby loss of PTEN drives wild-type RAC1 activation via PREX2 activation (24, 25). The gene discussed is PTEN; the disease is melanoma.